Navigation Links
Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
Date:12/14/2007

INDIANAPOLIS, Dec. 14 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Robert Conley, M.D., will join Lilly in January, 2008, as a Distinguished Lilly Scholar focusing on schizophrenia and other psychotic illnesses.

"We are absolutely delighted to have Dr. Conley join our team here at Lilly," said Jack Harris, M.D., vice president, U.S. Medical Division. "Rob is a well-known thought leader, clinician and scientist who brings important experience to Lilly as we continue to realize our vision of serving the patient. His experience will allow him to play a key scientific leadership role in our relationships with the U.S. physician community as well as the broader clinical and scientific communities."

Conley joins Lilly from the University of Maryland in Baltimore, where he is professor of psychiatry and pharmacy science. His work there focused on developing better treatments for patients with schizophrenia and other psychotic illnesses. With his colleagues at the Maryland Psychiatric Research Center and the National Institute on Drug Abuse, he also helped improve treatment for patients with poorly responsive schizophrenia through increased understanding of the most effective and safest ways to use antipsychotics.

After receiving his bachelor's degree from the John Hopkins University, Conley earned his medical degree from the University of Maryland in Baltimore. He did post-graduate work at the Western Psychiatric Institute & Clinic at the University of Pittsburgh before joining the faculty at the University of Maryland in Baltimore. He is an accomplished author and serves on numerous national peer-review boards.

"I am very pleased that Rob has decided to join Lilly," said Alan Breier, M.D., vice president and Lilly's chief medical officer. "He is an internationally recognized leader in schizophrenia research and will bring great technical depth and disease state knowledge to our company. Our commitment to neuroscience is quite strong, and the addition of Rob only strengthens our expertise in this area."

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
2. Immunotec Inc. announces retirement of President & CEO C.H. (Chuck) Roberts
3. Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
6. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
7. Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
8. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
9. Amarin Signs Agreement to Acquire Ester Neurosciences
10. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
11. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
Breaking Biology News(10 mins):